Can-Fite BioPharma Ltd.
PublicCan-Fite BioPharma Ltd. is now publicly traded
The data on this page reflects Can-Fite BioPharma Ltd.'s private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
Seed Round
Sep 10, 2026
Total Funding Raised
$8.31M
Company Overview
Can-Fite BioPharma Ltd. is a clinical-stage biopharmaceutical company that develops orally bioavailable small molecule therapeutic products for the treatment of cancer, liver, and inflammatory diseases.
Sector
Healthcare
AI Layer
Non-AI
Keywords
Can-Fite BioPharma Ltd. Comparables
Compare Can-Fite BioPharma Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Spero Biopharma | 59% |
Can-Fite BioPharma Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Sep 10, 2026 |
Can-Fite BioPharma Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access